Consistent with our findings, Hsu and collaborators showed that CSCs isolated from primary tumors of NSCLC patients using CD133, expressed higher levels of Nanog and SOX-2 [10]. This evidence concerns the gene PROM1 and non-small cell lung carcinoma.